These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38497109)

  • 1. Lymphadenectomy in clinically early epithelial ovarian cancer and survival analysis (LILAC): a Gynecologic Oncology Research Investigators Collaboration (GORILLA-3002) retrospective study.
    Yang EJ; Lee AJ; Hwang WY; Chang SJ; Kim HS; Kim NK; Kim Y; Kong TW; Lee EJ; Park SJ; Son JH; Suh DH; Son DH; Shim SH
    J Gynecol Oncol; 2024 Jul; 35(4):e75. PubMed ID: 38497109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is there any therapeutic role of pelvic and para-aortic lymphadenectomy in apparent early stage epithelial ovarian cancer?
    Bizzarri N; du Bois A; Fruscio R; De Felice F; De Iaco P; Casarin J; Vizza E; Chiantera V; Corrado G; Cianci S; Magni S; Ferrari D; Giuliani D; Harter P; Ataseven B; Bommert M; Perrone AM; Scambia G; Fagotti A
    Gynecol Oncol; 2021 Jan; 160(1):56-63. PubMed ID: 33168305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of pelvic and para-aortic lymphadenectomy on clinically-apparent stage I primary mucinous epithelial ovarian carcinoma: a multi-institutional study with propensity score-weighted analysis.
    Yoshihara M; Kajiyama H; Tamauchi S; Iyoshi S; Yokoi A; Suzuki S; Kawai M; Nagasaka T; Takahashi K; Matsui S; Kikkawa F
    Jpn J Clin Oncol; 2020 Feb; 50(2):145-151. PubMed ID: 31688935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to: Author's reply to: Lymphadenectomy in clinically early epithelial ovarian cancer and survival analysis (LILAC): a Gynecologic Oncology Research Investigators Collaboration (GORILLA-3002) retrospective study.
    Yang EJ; Shim SH
    J Gynecol Oncol; 2024 Jul; 35(4):e110. PubMed ID: 38991948
    [No Abstract]   [Full Text] [Related]  

  • 5. Adequate pelvic lymphadenectomy and survival of women with early-stage epithelial ovarian cancer.
    Matsuo K; Machida H; Mariani A; Mandelbaum RS; Glaser GE; Gostout BS; Roman LD; Wright JD
    J Gynecol Oncol; 2018 Sep; 29(5):e69. PubMed ID: 30022633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic value of selective lymphadenectomy in interval debulking surgery for stage IIIc and IV epithelial ovarian cancer.
    Song N; Gao Y
    Int J Gynecol Cancer; 2019 May; 29(4):761-767. PubMed ID: 30850437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for lymph node metastasis in apparent early-stage epithelial ovarian cancer: implications for surgical staging.
    Powless CA; Aletti GD; Bakkum-Gamez JN; Cliby WA
    Gynecol Oncol; 2011 Sep; 122(3):536-40. PubMed ID: 21636114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Surgery in early-stage ovarian cancer: Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa].
    Bolze PA; Collinet P; Golfier F; Bourgin C
    Gynecol Obstet Fertil Senol; 2019 Feb; 47(2):168-179. PubMed ID: 30686727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph node staging in grade 1-2 endometrioid ovarian carcinoma apparently confined to the ovary: Is it worth?
    Bizzarri N; Imterat M; Fruscio R; Giannarelli D; Perrone AM; Mancari R; Traut A; Rosati A; du Bois A; Ferrari D; De Iaco P; Ergasti R; Ataseven B; Bianchi T; Di Stanislao M; Perri MT; Heitz F; Concin N; Fanfani F; Vizza E; Scambia G; Harter P; Fagotti A
    Eur J Cancer; 2023 Dec; 195():113398. PubMed ID: 37890354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does complete-staging lymphadenectomy improve survival outcomes in stage I endometrioid epithelial ovarian carcinoma? A multi-institutional retrospective study with propensity score-weighted analysis.
    Yoshihara M; Tamauchi S; Iyoshi S; Kitami K; Uno K; Tano S; Matsui S; Kajiyama H
    Jpn J Clin Oncol; 2021 Mar; 51(3):387-392. PubMed ID: 33253382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Factors Affecting Lymph Node Metastasis in Clinical Stage I-II Epithelial Ovarian Cancer.
    Erdem B; Yüksel IT; Peker N; Ulukent SC; Aşıcıoğlu O; Özaydin IY; Ülker V; Akbayir O
    Oncol Res Treat; 2018; 41(7-8):444-448. PubMed ID: 29975960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective randomized multicenter trial for lymphadenectomy in early-stage ovarian cancer: LOVE study.
    Deng T; Liu K; Chen L; Chen X; Li HW; Guo H; Zhang H; Xiang L; Feng X; Wang X; Ngan HY; Zhao J; Zou D; Liu Q; Liu J
    J Gynecol Oncol; 2023 May; 34(3):e52. PubMed ID: 37116952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Significance of Lymph Node Dissection in Patients with Early Epithelial Ovarian Cancer.
    Bao R; Olivier M; Xiang J; Ye P; Yan X
    Ann Ital Chir; 2024; 95(4):628-635. PubMed ID: 39186355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of lymph node dissection on apparent Stage I epithelial ovarian carcinoma: A population-based study.
    Chen Q; Wang S; Lang JH
    Int J Gynaecol Obstet; 2021 Sep; 154(3):550-557. PubMed ID: 33507544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymph node metastasis in grossly apparent early-stage epithelial ovarian cancer: A retrospective clinical study at a tertiary institute.
    Zhu M; Li J; Lu L; Duan J; Jiang W
    J Cancer Res Ther; 2024 Aug; 20(4):1300-1305. PubMed ID: 39206992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphadenectomy in clinically early epithelial ovarian cancer and survival analysis: comment.
    Daungsupawong H; Wiwanitkit V
    J Gynecol Oncol; 2024 Jul; 35(4):e109. PubMed ID: 38991949
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of lymphadenectomy on survival after recurrence in patients with advanced ovarian cancer without suspected lymph node metastasis.
    Paik ES; Shim M; Choi HJ; Lee YY; Kim TJ; Lee JW; Kim BG; Bae DS; Choi CH
    Gynecol Oncol; 2016 Nov; 143(2):252-257. PubMed ID: 27567053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sentinel-node biopsy in early-stage ovarian cancer: preliminary results of a prospective multicentre study (SELLY).
    Uccella S; Nero C; Vizza E; Vargiu V; Corrado G; Bizzarri N; Ghezzi F; Cosentino F; Turco LC; Fagotti A; Scambia G
    Am J Obstet Gynecol; 2019 Oct; 221(4):324.e1-324.e10. PubMed ID: 31082385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of celiac lymph node involvement in patients after frontline treatment for advanced ovarian cancer.
    Angeles MA; Ferron G; Cabarrou B; Balague G; Martínez-Gómez C; Gladieff L; Pomel C; Martinez A
    Eur J Surg Oncol; 2019 Aug; 45(8):1410-1416. PubMed ID: 30857876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of systematic retroperitoneal lymphadenectomy during interval debulking surgery in advanced ovarian cancer patients.
    Iwase H; Takada T; Iitsuka C; Nomura H; Abe A; Taniguchi T; Takizawa K
    J Gynecol Oncol; 2015 Oct; 26(4):303-10. PubMed ID: 26197771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.